Presentation is loading. Please wait.

Presentation is loading. Please wait.

Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD,

Published byJeppe Andreasen Modified over 6 years ago

Similar presentations

Presentation on theme: "Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD,"— Presentation transcript:

1 Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD, Bernhard Odermatt, MD, Jens Kelm, PhD, Christian Breymann, MD, Matthias Gössi, PhD, Michele Genoni, MD, Gregor Zund, MD, Simon P. Hoerstrup, MD, PhD  The Annals of Thoracic Surgery  Volume 82, Issue 4, Pages (October 2006) DOI: /j.athoracsur Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Macroscopic appearance of tissue-engineered blood vessels. Vascular scaffolds of 0.5 cm diameter and 3 cm length fabricated from nonwoven polyglycolic acid mesh and poly-4-hydroxybutyric acid before seeding (A) and after in vitro culturing (B). Tissue-engineered blood vessels were intact, pliable, and densely covered with cells (B). The lumen was open, and the wall thickness was homogeneous at about 0.3 cm. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Histology and immunohistochemistry of tissue-engineered blood vessels. (A) Hematoxylin and eosin staining revealed a cellular tissue with an outer layer consisting of loosely arranged cells and a middle layer organized more compactly. The innermost layer consisted of endothelial cells. (B) Cells in the middle layer expressed α-smooth muscle actin. (C) A CD31-positive cell layer lined the lumen of the tissue-engineered blood vessels. Additionally, some cells expressing CD31 could be found in the middle layer. (D) Higher magnification of CD31-positive cells distant from the luminal cell lining. Arrows point at remnants of scaffold. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Morphology of the inner surfaces. Scanning electron micrographs show smooth inner surfaces of the tissue-engineered blood vessels densely covered with endothelial cells derived from endothelial progenitor cells (A) and human umbilical vein endothelial cells (B). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Quantification of extracellular matrix elements and cell number. Total cell number (represented as DNA) in tissue-engineered blood vessels was 90% of native tissue values; glycosaminoglycans (GAG) and collagen (hydroxyproline, HYP) were 62% and 1%, respectively. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Functional plasticity and bioactivity of endothelial cells. Both endothelial progenitor cell–derived endothelial cells (EPC) and human umbilical vein endothelial cells (HUVEC) expressed CD31 and thrombomodulin (TM) but lacked the expression of tissue factor (TF) (grey). After stimulation with tumor necrosis factor-α (black) the expression of thrombomodulin was decreased whereas the expression of tissue factor was upregulated. CD31 expression was not affected. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD,"

Similar presentations

Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.

Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.
In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,

In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,

Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,
BRCA1 Gene Mutation in Thymic Malignant Melanoma

BRCA1 Gene Mutation in Thymic Malignant Melanoma
In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.

In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.
Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,

Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,
Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.

Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.
Non-Hodgkin’s Lymphoma Presenting as a Large Chest Wall Mass

Non-Hodgkin’s Lymphoma Presenting as a Large Chest Wall Mass
Fariba Chalajour, MD, Laura A

Fariba Chalajour, MD, Laura A
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,

Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Chest Wall Angiolipoma Complicating Von Recklinghausen Disease

Chest Wall Angiolipoma Complicating Von Recklinghausen Disease
Biomatrix/Polymer Composite Material for Heart Valve Tissue Engineering  Christof Stamm, MD, Amir Khosravi, MD, Niels Grabow, MS, Kathleen Schmohl, PhD,

Biomatrix/Polymer Composite Material for Heart Valve Tissue Engineering  Christof Stamm, MD, Amir Khosravi, MD, Niels Grabow, MS, Kathleen Schmohl, PhD,
Experimental generation of a tissue-engineered functional and vascularized trachea  Thorsten Walles, MD, Bettina Giere, Michael Hofmann, PhD, Johanna Schanz,

Experimental generation of a tissue-engineered functional and vascularized trachea  Thorsten Walles, MD, Bettina Giere, Michael Hofmann, PhD, Johanna Schanz,
Vascular anastomoses with laser energy

Vascular anastomoses with laser energy
Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts  Damiano Mugnai, MD, Jean-Christophe Tille, MD,

Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts  Damiano Mugnai, MD, Jean-Christophe Tille, MD,
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,

Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.

Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.
Fast-Growing Large Cell Neuroendocrine Carcinoma of Mediastinum

Fast-Growing Large Cell Neuroendocrine Carcinoma of Mediastinum

Similar presentations

Ads by Google